Efficacy of COVID-19 Oral antivirals in hospitalised oldest-old with high morbidity burden: a target trial emulation study
Molnupiravir and nirmatrelvir-ritonavir are moderately effective in reducing mortality risk among hospitalised oldest-old patients with COVID-19, regardless of their vaccination status.
Authors
- Ching‐Lung Cheung (ORCID: https://orcid.org/0000-0002-6233-9144)
- Celine Sze Ling Chui (ORCID: https://orcid.org/0000-0003-1513-8726)
- Eric Yuk Fai Wan (ORCID: https://orcid.org/0000-0002-6275-1147)
- Esther W. Chan (ORCID: https://orcid.org/0000-0002-7602-9470)
- Francisco Tsz Tsun Lai (ORCID: https://orcid.org/0000-0002-9121-1959)
- Boyuan Wang (ORCID: https://orcid.org/0000-0003-1854-6178)
- Ian Chi Kei Wong (ORCID: https://orcid.org/0000-0001-8242-0014)
- Xue Li (ORCID: https://orcid.org/0000-0003-4836-7808)
- Cuiling Wei
Institutions
- Macau University of Science and Technology (MO)
- Aston University (GB)
- Hong Kong Science and Technology Parks Corporation (HK)
- University of Hong Kong - Shenzhen Hospital (CN)
- Laboratory of Data Discovery for Health (HK)
- University of Hong Kong (HK)
Publication Details
- Journal
- Age and Ageing
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1093/ageing/afae180
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.78